Dxdiscovery, Inc.

Reno, NV

UEI
QLC3LDVHBSP8
CAGE
6TCU4
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Subchapter S Corporation
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
1131 Sentinel Cir, Reno, NV 89509, USA
Website
dxdiscovery.com
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract awards

Award Agency Obligated Awarded
Develop antigen detection immunoassay for coccidiodes galactomannan for phase II 75N93022C00028 National Institute of Allergy and Infectious Diseases (NIH) $1,469,691
Develop a coccidioides-specific antigen in patient serum or urine and develop an immunoassay for coccidioides… 75N93020C00035 National Institute of Allergy and Infectious Diseases (NIH) $299,399
R & D effort-sbir sequential PH II award total award amount 999,995.10 W911QY18C0005 Defense Contract Management Agency $997,495
Sbir proposal: H151-006-0012 W81XWH15C0163 Medical Command (Army) $149,715
Option exercise W911QY15C0058 ACC Aberdeen Proving Ground $999,822

Latest 5 listed here. See the rest on GovTribe.

Grant awards

Award Agency Obligated Awarded
Immunoassay for early diagnosis of mucormycosis R43AI140817 National Institute of Allergy and Infectious Diseases (NIH) $595,146
Point of care immunoassay for rapid diagnosis of tinea capitis R43EB023408 National Institute of Biomedical Imaging and Bioenginering (NIH) $420,640
Lateral flow immunoassay for rapid diagnosis of tinea capitis and onychomycosis R44EB023408 National Institute of Biomedical Imaging and Bioenginering (NIH) $1,482,335
Identification of borrelia burgdorferi diagnostic biomarkers in humans and nonhum R41AI114049 National Institutes of Health $591,671
Point-of-care immunoassay for early diagnosis of pertussis R44AI109891 National Institute of Allergy and Infectious Diseases (NIH) $8,150,612

Latest 5 listed here. See the rest on GovTribe.

Quick answers

Is Dxdiscovery, Inc. registered in SAM.gov?

Yes. Dxdiscovery, Inc.'s SAM.gov registration is active through January 12, 2027.

What is Dxdiscovery, Inc.'s CAGE code?

Dxdiscovery, Inc.'s CAGE code is 6TCU4, and its Unique Entity ID (UEI) is QLC3LDVHBSP8.

What is Dxdiscovery, Inc.'s most recent federal award?

Dxdiscovery, Inc.'s most recent federal contract award is Develop antigen detection immunoassay for coccidiodes galactomannan for phase II (75N93022C00028), from National Institute of Allergy and Infectious Diseases (NIH), on September 30, 2022.

On GovTribe

See Dxdiscovery, Inc.'s full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login

Find teaming partners on GovTribe